STACY MORAN: Open Payments
NPI 1295849859 · INDIANA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,042 in 93 payments from 14 companies in 2025. Trend: 2023 $2,933 · 2024 $8,008 · 2025 $3,042
Food & beverage: $1,556Speaker / faculty: $1,375Education: $111
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $1,545 |
| Teva Pharmaceuticals USA, Inc. | 21 | $371 |
| Otsuka America Pharmaceutical, Inc. | 15 | $266 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $161 |
| Vanda Pharmaceuticals Inc. | 7 | $148 |
| Neurocrine BioSciences, Inc. | 6 | $104 |
| Janssen Pharmaceuticals, Inc | 5 | $95 |
| Lundbeck LLC | 4 | $80 |
| Collegium Pharmaceutical, Inc. | 3 | $66 |
| Alkermes, Inc. | 3 | $63 |
Products named: VRAYLAR, REXULTI, CAPLYTA, FANAPT, UZEDY, AUSTEDO XR, INGREZZA, INVEGA SUSTENNA.
Industry payments across PA — which companies pay providers there.
